Atlantic Peptides Teams Up with a United Kingdom Company to Offer cGMP Peptides and API

Scarborough ME (PRWEB) May 15 2013 Atlantic Peptides LLC a leader in custom synthetic peptide chemistry service announced today the collaboration with a United Kingdom company to offer cGMP peptides and API. The facility houses over 10000 sq ft which inco

Atlantic Peptides LLC, a leader in custom synthetic peptide chemistry service announced today the collaboration with a United Kingdom company to offer cGMP peptides and API. The facility houses over 10,000 sq ft which incorporates eight cGMP suites. This will allow current and future customers in their research and in-process projects from pre-clinical toxicology studies through the early stage clinical trials.

The facility houses over 10,000 square feet of modern laboratories which incorporates eight cGMP suites. The facility has been designed and built to meet national and international standards (EC guidance for GMP, Eudralex Vol. 4, Part I, II and Annex 1; ICH Q7A; US Federal Standard 209 E; and the ISO classification) required for API manufacture.

With the increasing focus on peptide therapeutic agents for healthcare, we aim to offer a complete solution to the pharmaceutical industry, by supplying peptides for pre-GMP research studies through to cGMP grade peptides.

About Atlantic Peptides
Atlantic Peptides scientific is a trusted provider of high quality peptide based products to pharmaceutical and biotechnology companies and academic researchers. Atlantic Peptides offers catalog peptides, custom peptide synthesis, peptide arrays and libraries, cGMP manufacturing of peptide APIs and Generics and is a world leader in complex peptide modification services. Atlantic Peptides provides FFS and FTE services as well as process development and validation, stability studies, regulatory support and documentation. For more information please visit us at http://www.atlanticpeptides.com

(Date:12/8/2016)... TAMPA, Fla. , Dec. 8, 2016 /PRNewswire/ ... biopharmaceutical company that discovers, develops and plans to ... today that its shares of common stock were approved ... stock will begin trading on the OTCQX, effective ... To qualify for the OTCQX market, companies must ...

(Date:12/7/2016)... ... December 07, 2016 , ... ... I/II dose escalation and expansion clinical trial for its lead drug candidate, AC0010, ... purpose of the trial was to determine the safety, antitumor activity, and recommended ...

(Date:12/7/2016)... /PRNewswire/ - Zenith Capital Corp. ("Zenith" or the "Company") announces webcast ... the Company,s Annual and Special Meeting. The ... on Thursday, December 15, 2016 at Mount Royal ... 4825 Mount Royal Gate SW, Calgary, Alberta ... and management information circular, containing the matters to be considered ...

(Date:12/6/2016)... Dec. 6, 2016 Valencell , the leading ... has seen a third consecutive year of triple digit ... in 2016 with a 360 percent increase in companies ... increase was driven by sales of its wrist and ... in its technology for hearables for fitness and healthcare ...